|
⚲
|
| Keyboard |
| Astria Therapeutics Inc
✚
|
|
|---|---|
| CIK # | 0001454789 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 10-K | [0001454789] | |
| 10-Q | [0001454789] | |
| 3 | [0001454789] | |
| 4 | [0001454789] | |
| 5 | [0001454789] | |
| 8-K | [0001454789] | |
| D | [0001454789] | |
| SC 13D | [0001454789] | |
| SC 13G | [0001454789] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Catabasis Pharmaceuticals Inc ATXS
Common Stock
|
2026-01-23 | Disposed to issuer | 10 | ||
|
Catabasis Pharmaceuticals Inc ATXS
Common Stock
|
2026-01-23 | Disposed to issuer | 263,321 | ||
|
Catabasis Pharmaceuticals Inc ATXS
Common Stock
|
2026-01-23 | Disposed to issuer | 45 | ||
|
Catabasis Pharmaceuticals Inc ATXS
Common Stock
|
2026-01-23 | Disposed to issuer | 4,377 | ||
|
Catabasis Pharmaceuticals Inc ATXS
Common Stock
|
2026-01-23 | Disposed to issuer | 45 | ||
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2026-01-23 | Disposed to issuer | 8,333 | ||
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2026-01-23 | Disposed to issuer | 14,100 | ||
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2026-01-23 | Disposed to issuer | 14,100 | ||
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2026-01-23 | Disposed to issuer | 14,166 | ||
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2026-01-23 | Disposed to issuer | 26,550 | ||
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2026-01-23 | Disposed to issuer | 262,500 | ||
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2026-01-23 | Disposed to issuer | 80,000 | ||
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2026-01-23 | Disposed to issuer | 761,000 | ||
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2026-01-23 | Disposed to issuer | 195,000 | ||
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2026-01-23 | Disposed to issuer | 262,500 | ||
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2026-01-23 | Disposed to issuer | 20,000 | ||
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2026-01-23 | Disposed to issuer | 32,812 | ||
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2026-01-23 | Disposed to issuer | 14,100 | ||
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2026-01-23 | Disposed to issuer | 26,550 | ||
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2026-01-23 | Disposed to issuer | 8,333 | ||
| showing 20 of 200 most recent transactions | |||||